Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Dec 1;168(6):2183-91.
doi: 10.1084/jem.168.6.2183.

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma

Y Kawakami  1 , S A Rosenberg, M T Lotze
Affiliations

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma

Y Kawakami et al. J Exp Med. .

Abstract

Addition of IL-4 (1,000 U/ml) to either high or low concentrations of IL-2 augmented tumor-infiltrating lymphocytes (TIL) growth from human melanoma. Weekly restimulation with irradiated tumor cells in conjunction with IL-4 allowed enhanced growth of TIL. With low-dose IL-2 (10 U/ml) and IL-4, expanded TIL had little cytolytic activity against Daudi or allogeneic tumors. Further, IL-4 augmented the total lytic activity against autologous tumors in most cases. With high-dose IL-2 (1,000 U/ml), IL-4 addition decreased nonspecific killing activity against Daudi or allogeneic melanomas in many cases, and reciprocally augmented cytolytic activity against the autologous melanoma in many cases. This suggests the possible use of IL-4 in cancer therapy, especially in adoptive cellular immunotherapy using TIL or in conjunction with IL-2 administration.

PubMed Disclaimer

References

    1. Cancer Res. 1981 Nov;41(11 Pt 1):4420-5 - PubMed
    1. J Immunol. 1988 Jul 1;141(1):29-36 - PubMed
    1. J Immunol. 1986 Oct 15;137(8):2572-8 - PubMed
    1. J Immunol. 1987 Feb 1;138(3):989-95 - PubMed
    1. N Engl J Med. 1987 Apr 9;316(15):889-97 - PubMed